FLUTICASONE PROPIONATE 250 MCG + SALMETEROL 50MCG
RESFLU – S 250 DPI CAPS is a dual-action Dry Powder Inhaler (DPI) therapy designed for the effective management of asthma and chronic obstructive pulmonary disease (COPD). Combining the potent anti-inflammatory properties of Fluticasone Propionate with the long-acting bronchodilating action of Salmeterol, this formulation offers sustained symptom control and improved respiratory function.
Composition:
- Fluticasone Propionate 250 mcg: A corticosteroid that reduces airway inflammation and prevents flare-ups.
- Salmeterol 50 mcg: A long-acting beta-2 agonist (LABA) that relaxes airway muscles for 12-hour relief.
Packing:
- 30 Capsules Per Pack for a month-long respiratory care regimen.
Key Features of RESFLU – S 250 DPI CAPS
- Dual Mechanism of Action: Targets both airway inflammation and bronchoconstriction for comprehensive respiratory support.
- Long-Lasting Relief: Provides up to 12 hours of symptom control, reducing the frequency of inhaler use.
- Convenient DPI Format: Ensures precise dosing and easy administration for enhanced patient compliance.